Friday, October 28, 2016: 8:30 AM-10:00 AM
Room: Theater A & B

At the conclusion of this session, participants will be able to:
- identify complicating factors in HIV-infected patients
- apply strategies to address treatment complications in HIV-infected patients
- choose between different treatment strategies in managing HIV-infected patients (case study)








J. Eron,
Bristol Myers Squibb:
Consultant
and
Investigator
,
Consulting fee
and
Research grant
ViIV Healthcare:
Consultant
and
Investigator
,
Consulting fee
and
Research grant
Janssen:
Consultant
and
Investigator
,
Consulting fee
and
Research grant
Gilead Sciences:
Consultant
and
Investigator
,
Consulting fee
and
Research grant
Merck:
Consultant
,
Consulting fee
B. Taiwo, ViiV: Consultant and Investigator , Consulting fee and Research grant
Gilead: Consultant , Consulting fee
P. Sax, AbbVie: Scientific Advisor , Consulting fee
BMS: Grant Investigator and Scientific Advisor , Consulting fee and Research grant
GlaxoSmithKline/ViiV: Grant Investigator and Scientific Advisor , Consulting fee and Research grant
Gilead: Grant Investigator and Scientific Advisor , Consulting fee and Research grant
Janssen: Scientific Advisor , Consulting fee
Merck: Scientific Advisor , Consulting fee
B. Wood, None
See more of: Interactive Session